$1.25
0.08[6.84%]
At close: Apr 26
$1.25
0[0.00%]
After Hours: 6:37PM EDT
Hoth Therapeutics
(NASDAQ:HOTH)Latest News for Hoth Therapeutics Stock (NASDAQ:HOTH)
Hoth Therapeutics Stock (NASDAQ: HOTH)
Categories: All
Friday, April 05, 2024
Tuesday, April 02, 2024
Wednesday, March 27, 2024
Tuesday, March 19, 2024
- Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionAvi Kapoor - Mar 19, 2024, 1:48PM
- Why Is Alzheimer's-Focused Hoth Therapeutics Stock Trading Higher On Tuesday?Vandana Singh - Mar 19, 2024, 1:01PM
- Hoth Therapeutics shares are trading higher after the company announced pre-clinical research showcasing the potential of HT-ALZ in Alzheimer's disease.Benzinga Newsdesk - Mar 19, 2024, 9:13AM
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga Insights - Mar 19, 2024, 9:05AM
- Market-Moving News for March 19thBenzinga Newsdesk - Mar 19, 2024, 8:41AM
- Hoth Therapeutics Says HT-ALZ Emerges As A Promising Novel Solution For Combating Neuroinflammation And Cognitive Deficits Associated With Alzheimer's Disease.Benzinga Newsdesk - Mar 19, 2024, 8:22AM
- Hoth Therapeutics Announces Data In Completed Study Of Alzheimer's Disease Pre-Clinical Treatment With HT-ALZBenzinga Newsdesk - Mar 19, 2024, 8:22AM
Monday, February 26, 2024
Monday, February 05, 2024
Thursday, January 18, 2024
Wednesday, December 27, 2023
- Why Hoth Therapeutics Shares Are Rising TodayNabaparna Bhattacharya - Dec 27, 2023, 10:37AM
- Hoth Therapeutics shares are trading higher after the company announced expansion of its FDA cleared First-In-Human clinical trial for cancer patients of HT-001 at the University of Miami.Benzinga Newsdesk - Dec 27, 2023, 9:15AM
- Hoth Therapeutics Announces Expansion Of FDA Cleared First-In-Human Clinical Trial For Cancer Patients Of HT-001 At University Of Miami For The Treatment Of Skin Toxicities Associated With EGFRi TreatmentsBenzinga Newsdesk - Dec 27, 2023, 8:22AM
Tuesday, December 05, 2023
Tuesday, November 14, 2023
Thursday, October 05, 2023
- Stocks That Hit 52-Week Lows On ThursdayBenzinga Insights - Oct 5, 2023, 1:22PM
- Hoth Therapeutics Announces Merveille.ai Artificial intelligence Initiative For Drug Discovery; The New Wholly Owned Subsidiary Will Screen For Rare Disease TherapeuticsBenzinga Newsdesk - Oct 5, 2023, 10:06AM
- Hoth Therapeutics On Oct. 4, Filed Articles Of Incorporation With State Of Nevada For Formation Of New Wholly-Owned Subsidiary, Merveille.aiBenzinga Newsdesk - Oct 5, 2023, 8:18AM
Monday, October 02, 2023
Thursday, September 14, 2023
Wednesday, September 13, 2023
- Hoth Therapeutics' Investigational Cancer Drug Shows Encouraging Preclinical Activity In Stomach CancersVandana Singh - Sep 13, 2023, 1:50PM
- Hoth Therapeutics Announces $2.89M Registered Direct Offering Of 1.1M Shares Of Stock Priced At-The-Market Under Nasdaq RulesBenzinga Newsdesk - Sep 13, 2023, 1:46PM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Sep 13, 2023, 9:06AM
- Hoth Therapeutics shares are trading higher after the company announced HT-KIT, a new molecular entity, for the treatment of advance systemic mastocytosis killed cancer cells in both gastrointestinal stromal tumors and acute myeloid leukemina.Benzinga Newsdesk - Sep 13, 2023, 8:28AM
- Hoth Therapeutics Says HT-KIT, A New Molecular Entity, For Advance Systemic Mastocytosis Shows Cancer Cells Killing In Both Gastrointestinal Stromal Tumors And Acute Myeloid Leukemia In Preclinical StudyBenzinga Newsdesk - Sep 13, 2023, 8:20AM
Tuesday, September 12, 2023
Monday, September 11, 2023
Wednesday, August 23, 2023
Wednesday, August 09, 2023
Tuesday, July 25, 2023
Wednesday, July 19, 2023
Friday, July 07, 2023
Thursday, June 22, 2023
Tuesday, June 20, 2023
Wednesday, June 14, 2023
- Hoth Therapeutics shares are trading higher after the company received IRB approval to proceed with its first-in-human phase 2a trial of HT-001 for skin toxicities associated with epidermal growth factor receptor inhibitorsBenzinga Newsdesk - Jun 14, 2023, 8:18AM
- Hoth Therapeutics Announces IRB Approval For FDA Cleared First-In-Human Clinical Trial Of HT-001 At Second Clinical SiteBenzinga Newsdesk - Jun 14, 2023, 8:13AM
Wednesday, June 07, 2023
- Why Couchbase Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - Jun 7, 2023, 2:02PM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Jun 7, 2023, 9:06AM
- Why Yext Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving PremarketLisa Levin - Jun 7, 2023, 8:07AM
- Fear & Greed Index Moves To 'Extreme Greed' Zone After US Stocks Settle HigherLisa Levin - Jun 7, 2023, 3:47AM